![](\"https:\/\/cannabiscultivatornews.com\/home\/wp-content\/uploads\/2025\/10\/MM_Bill_Tracker_V5_blank-47.jpg\"){kind=tracking}
<\/p>\n <\/p>\n
Arizona officials have approved and funded a first-in-the-nation clinical trial investigating the potential of whole mushroom psilocybin to treat post-traumatic stress disorder (PTSD) in first responders and military veterans\u2014with authorization from the federal Food and Drug Administration (FDA).<\/p>\n
The state-funded study is being spearheaded by the Scottsdale Research Institute (SRI), with support from the research firm Alira Health. The initial trial will involve eight police officers, eight firefighters and eight military veterans diagnosed with PTSD who will receive the psychedelic in a medically supervised environment.<\/p>\n
With backing from the Arizona Department of Health Services (ADHS), the historic research project is being made possible by the enactment of a spending bill Gov. Katie Hobbs (D) signed into law in 2023 that earmarked $5 million in grants for psilocybin studies<\/a>.<\/p>\n \u201cScientific progress is essential to ensuring that our healthcare decisions are informed by rigorous research and sound data,\u201d Nicole Nichols, executive director at SRI, said in a press release on Tuesday.<\/p>\n The FDA-controlled trial will involve 24 participants with PTSD who will take 30 milligrams of psilocybin from about 4.5 grams of whole psilocybin mushrooms, grown at SRI\u2019s facility that operates under a Drug Enforcement Administration (DEA) Schedule I manufacturer license.<\/p>\n Arizona Sen. Kevin Payne (R), who championed the psilocybin research funding legislation, said the state is \u201cproud to lead the way with this pioneering study, which reflects our commitment to evidence-based, responsible exploration of new treatment options for patients in need.\u201d<\/p>\n SRI\u2019s Sue Sisley said that the landmark clinical trial \u201creflects our mission to deliver real-world data that can guide policy and expand access to promising treatments for patients with PTSD.\u201d<\/p>\n \u2014 This latest development comes months after Arizona lawmakers approved two different bills focused on psychedelic therapy<\/a>.<\/p>\n The Senate passed a bill to create an advisory board tasked with studying the science of psilocybin, as well as state and federal policies surrounding the psychedelic, while the House separately approved a measure to fund clinical trials on ibogaine.<\/p>\n An earlier version of the Senate psilocybin bill moved through both chambers last year with regulated therapeutic access provisions for adults, but it was vetoed by the Democratic governor<\/a>, who argued that \u201cwe do not yet have the evidence needed to support widespread clinical expansion.\u201d<\/p>\n Meanwhile, ahead of the House vote on the ibogaine research bill, former U.S. Sen. Kyrsten Sinema (I-AZ)\u2014who also championed psychedelics reform while serving in Congress\u2014called on the state legislature to pass the legislation, while\u00a0pledging to personally raise $5 million in philanthropic donations to support the psychedelic research<\/a>\u00a0if it\u2019s is ultimately enacted.<\/p>\n Separately, Hobbs signed a bill into law last year that would allow firefighters and peace officers with PTSD to\u00a0get workers\u2019 compensation coverage for MDMA therapy<\/a>\u00a0if it is federally legalized.<\/p>\n Photo courtesy of Dick Culbert<\/a>.<\/em><\/p>\n The post Arizona Approves First-Of-Its-Kind Study Exploring Whole Mushroom Psilocybin Therapy To Treat PTSD<\/a> appeared first on Marijuana Moment<\/a>.<\/p>\n
Arizona officials have approved and funded a first-in-the-nation clinical trial investigating the potential of whole mushroom psilocybin to treat post-traumatic stress disorder (PTSD) in first responders and military veterans\u2014with authorization from the federal Food and Drug Administration (FDA). The state-funded study is being spearheaded by the Scottsdale Research Institute (SRI),Continue Reading<\/a><\/span><\/p>\n","protected":false},"author":458,"featured_media":84030,"comment_status":"false","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[18,81],"tags":[],"_links":{"self":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/84029"}],"collection":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/users\/458"}],"replies":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/comments?post=84029"}],"version-history":[{"count":1,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/84029\/revisions"}],"predecessor-version":[{"id":84031,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/84029\/revisions\/84031"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/media\/84030"}],"wp:attachment":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/media?parent=84029"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/categories?post=84029"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/tags?post=84029"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nMarijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills<\/a> in state legislatures and Congress this year. Patreon supporters<\/a> pledging at least $25\/month get access to our interactive maps, charts and hearing calendar so they don\u2019t miss any developments.<\/strong>
\n![\"\"](\"https:\/\/cannabiscultivatornews.com\/home\/wp-content\/uploads\/2025\/10\/MM_Bill_Tracker_V5_blank-46.jpg\"){kind=tracking}
<\/a>
\nLearn more about our marijuana bill tracker<\/a> and become a supporter on Patreon<\/a> to get access.
\n\u2014<\/strong><\/p>\n
\n
\nRead More: Arizona Approves First-Of-Its-Kind Study Exploring Whole Mushroom Psilocybin Therapy To Treat PTSD<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"